- 5 Resultados
precio mínimo: € 14,57, precio máximo: € 54,15, precio promedio: € 43,48
1
NeuroPET
Pedir
por Springer.com
€ 53,49
Envío: € 0,001
PedirEnlace patrocinado

NeuroPET - libro nuevo

ISBN: 9783540006916

Positron emission tomography (PET) provides unbiased in vivo measurement of local tracer activity at very high sensitivity. This is a unique property unmatched by other imaging modalities… Más…

Nr. 978-3-540-00691-6. Gastos de envío:Worldwide free shipping, , DE. (EUR 0.00)
2
NeuroPET: Positron Emission Tomography in Neuroscience and Clinical Neurology - Herholz, K. Herscovitch, P. Heiss, W.-D.
Pedir
por Amazon.de (Intern. Bücher)
€ 44,71
Envío: € 3,001
PedirEnlace patrocinado

Herholz, K. Herscovitch, P. Heiss, W.-D.:

NeuroPET: Positron Emission Tomography in Neuroscience and Clinical Neurology - encuadernado, tapa blanda

2004, ISBN: 9783540006916

Springer, Gebundene Ausgabe, Auflage: 2004, 312 Seiten, Publiziert: 2004-06-16T00:00:01Z, Produktgruppe: Buch, Hersteller-Nr.: 66 illus. 1.69 kg, Neurochirurgie, Chirurgie, Medizin, Kateg… Más…

IN - IndiaGastos de envío:Gewöhnlich versandfertig in 6 bis 7 Tagen. Die angegebenen Versandkosten können von den tatsächlichen Kosten abweichen. (EUR 3.00) Prestivo2
3
NeuroPET: Positron Emission Tomography in Neuroscience and Clinical Neurology - Herholz, K. Herscovitch, P. Heiss, W.-D.
Pedir
por Amazon.de (Intern. Bücher)
€ 50,50
Envío: € 3,001
PedirEnlace patrocinado
Herholz, K. Herscovitch, P. Heiss, W.-D.:
NeuroPET: Positron Emission Tomography in Neuroscience and Clinical Neurology - encuadernado, tapa blanda

2004

ISBN: 9783540006916

Springer, Gebundene Ausgabe, Auflage: 2004, 312 Seiten, Publiziert: 2004-06-16T00:00:01Z, Produktgruppe: Buch, Hersteller-Nr.: 66 illus. 1.69 kg, Neurochirurgie, Chirurgie, Medizin, Kateg… Más…

Gastos de envío:Gewöhnlich versandfertig in 11 bis 12 Tagen. Die angegebenen Versandkosten können von den tatsächlichen Kosten abweichen. (EUR 3.00) preigu
4
NeuroPET Positron Emission Tomography in Neuroscience and Clinical Neurology - Herholz, K.; Heiss, W. -D.; Herscovitch, P.
Pedir
por Achtung-Buecher.de
€ 54,15
Envío: € 0,001
PedirEnlace patrocinado
Herholz, K.; Heiss, W. -D.; Herscovitch, P.:
NeuroPET Positron Emission Tomography in Neuroscience and Clinical Neurology - encuadernado, tapa blanda

2004, ISBN: 3540006915

2004 Gebundene Ausgabe Medizin / Nuklearmedizin, Nuklearmedizin, Radiologie / Nuklearmedizin, PET - Positronen-Emissions-Tomographie , Neurologie und klinische Neurophysiologie, Psychia… Más…

Gastos de envío:Versandkostenfrei innerhalb der BRD. (EUR 0.00) MARZIES.de Buch- und Medienhandel, 14621 Schönwalde-Glien
5
Neuropet: tomografía por emisión de positrones en neurociencia y neurología clínica
Pedir
por ebay.es
€ 14,57
Envío: € 32,071
PedirEnlace patrocinado
Neuropet: tomografía por emisión de positrones en neurociencia y neurología clínica - libro usado

ISBN: 3540006915

Good Used Other, Festpreisangebot, [LT: FixedPrice], [PU: Springer, Berlin/Heidelberg]

98.7. Gastos de envío:Versand zum Fixpreis, 894** Sparks. (EUR 32.07) alibrisbooks

1Dado que algunas plataformas no nos comunican las condiciones de envío y éstas pueden depender del país de entrega, del precio de compra, del peso y tamaño del artículo, de una posible membresía a la plataforma, de una entrega directa por parte de la plataforma o a través de un tercero (Marketplace), etc., es posible que los gastos de envío indicados por eurolibro/terralibro no concuerden con los de la plataforma ofertante.

Datos bibliográficos del mejor libro coincidente

Detalles del libro
NeuroPET: Positron Emission Tomography in Neuroscience and Clinical Neurology

This is the only comprehensive and up-to-date book on neurological PET. Its goal is to facilitate cooperation between PET experts, neuroscientists and clinicians. We review PET in neuroscience with particular emphasis on findings that indicate its potential for improving diagnosis and treatment in neurology and psychiatry. We want to improve the transfer of the huge scientific developments in brain PET into clinical care to produce tangible human benefit. We therefore focus on practical and potentially clinically relevant issues and identify solid ground as well as open questions. In addition, the book includes major chapters on the methodological background, including tracer physiology and kinetic modeling, and a comprehensive literature review. The book contains a CD-ROM with video clips and interactive navigation in 3D data sets that illustrate the information contained in PET images in major neurological diseases and its potential to improve diagnosis and neurosurgical planning in brain tumors. TOC:Clinical Studies: Dementia and memory disorders. Movement disorders. Brain tumors. Cerebrovascular disease. Epilepsy. Other neurological disorders. Psychiatric disorders.- Imaging brain function: Blood-brain barrier transfer. Cerebral blood flow (CBF). Oxygen consumption. Glucose consumption. Influence of brain function on CBF and metabolism. Tissue oxygen pressure and pH. Amino acid transport and protein synthesis. Nucleosides and DNA synthesis. Molecular imaging. Dopamine system. Cholinergic system. Serotonin system. GABA. Glutamate and NMDA receptors. Adenosine receptors. Histamine receptors. Cannabinoid receptors. Opioid receptors and sigma receptor. Steroid receptors. Secondary neurotransmitters.- Data acquisition, reconstruction, modeling, statistics: Positron emitters and tracers. Scanners and detector systems. Data acquisition. Image reconstruction. Motion detection and correction. Data visualization. Anatomical standardization. Physiological modeling. Quantitative data analysis.

Detalles del libro - NeuroPET: Positron Emission Tomography in Neuroscience and Clinical Neurology


EAN (ISBN-13): 9783540006916
ISBN (ISBN-10): 3540006915
Tapa dura
Tapa blanda
Año de publicación: 2004
Editorial: Springer

Libro en la base de datos desde 2007-05-31T15:16:56+02:00 (Madrid)
Página de detalles modificada por última vez el 2024-03-13T19:46:16+01:00 (Madrid)
ISBN/EAN: 3540006915

ISBN - escritura alterna:
3-540-00691-5, 978-3-540-00691-6
Mode alterno de escritura y términos de búsqueda relacionados:
Autor del libro: dieter wolf, heiss, karl wolf, wolf peter, herholz, karl hölz, holz karl, heilmann
Título del libro: neurology, neuroscience, neuropet, positron emission tomography, clinical pet pet, rom


Datos del la editorial

Autor: K. Herholz
Título: NeuroPET - Positron Emission Tomography in Neuroscience and Clinical Neurology
Editorial: Springer; Springer Berlin
297 Páginas
Año de publicación: 2004-06-16
Berlin; Heidelberg; DE
Peso: 0,768 kg
Idioma: Inglés
54,99 € (DE)

SF; BB; DB; Nuclear Medicine; Hardcover, Softcover / Medizin/Klinische Fächer; Nuklearmedizin; Verstehen; Medizin, Gesundheit; Alzheimer; Nuclear medicine; Tumor; adenosine; cerebrovascular disease; dementia; diagnosis; neurology; neuroradiology; neuroscience; neurosurgery; physiology; positron emission tomography; psychiatric disorder; psychiatry; Neurosciences; Neuroradiology; Neurology; Neurosurgery; Psychiatry; Nuclear Medicine; Neuroscience; Neuroradiology; Neurology; Neurosurgery; Psychiatry; Neurowissenschaften; Medizinische Bildverarbeitung: Radiologie; Neurologie und klinische Neurophysiologie; Neurochirurgie; Psychiatrie; BC; EA

1 Introduction.- 2 Clinical Studies.- 2.1 Dementia and Memory Disorders.- 2.1.1 Clinical and Research Issues.- 2.1.2 Alzheimer’s Disease and Mild Cognitive Impairment.- 2.1.2.1 Cerebral Glucose Metabolism.- 2.1.2.2 Cholinergic Degeneration.- 2.1.2.3 Other Receptors and Transmitters.- 2.1.2.4 Amyloid Imaging.- 2.1.2.5 Activation Studies.- 2.1.3 Dementia with LewyBodies.- 2.1.4 Frontotemporal Dementia and Related Disorders.- 2.1.5 Vascular Dementia.- 2.1.6 Creutzfeldt-Iakob Disease.- 2.1.7 Other Memory Disorders.- 2.1.7.1 Hypoxic and Global Ischemic Brain Damage.- 2.1.7.2 Other Amnesic Syndromes.- 2.2 Movement Disorders.- 2.2.1 Idiopathic Parkinson Disease.- 2.2.1.1 Diagnostic Issues.- 2.2.1.2 Dopamine Synthesis.- 2.2.1.3 Dopamine Release and Turnover.- 2.2.1.4 Dopamine Transporters.- 2.2.1.5 Vesicular Monoamine Transporter.- 2.2.1.6 Dopamine Receptors.- 2.2.1.7 Mesocortical Dopaminergic Innervation.- 2.2.1.8 Other Transmitters.- 2.2.1.9 Resting Glucose Metabolism.- 2.2.1.10 Activation Studies.- 2.2.1.11 Familial PD.- 2.2.1.12 Disease Progression.- 2.2.1.13 Depression in PD.- 2.2.1.14 Improving and Understanding Treatment Effects.- 2.2.2 Multiple System Atrophy.- 2.2.2.1 Olivo-ponto-cerebellar Atrophy.- 2.2.2.2 Striatonigral Degeneration.- 2.2.2.3 Shy-Drager Syndrome.- 2.2.3 Other Neurodegenerative Disorders.- 2.2.3.1 Progressive Supranuclear Palsy.- 2.2.3.2 Corticobasal Degeneration.- 2.2.3.3 Disorders with Abnormal Deposition of Metals.- 2.2.3.4 Parkinsonism Attributable to Toxic and Inflammatory Brain Damage.- 2.2.3.5 Amyotrophic Lateral Sclerosis.- 2.2.3.6 Other Rare Disorders.- 2.2.4 Hyperkinetic Syndromes.- 2.2.4.1 Huntington’s Chorea (Huntington Disease).- 2.2.4.2 Other Choreic Disorders.- 2.2.4.3 Restless LegsSyndrome.- 2.2.4.4 Essential and Orthostatic Tremor.- 2.2.4.5 Tourette Syndrome.- 2.2.5 Dystonia and Related Disorders.- 2.2.5.1 Idiopathic Dystonia and Torticollis.- 2.2.5.2 DOPA-responsiveDystonia.- 2.2.5.3 Dystonia Attributable to Localized Lesions or Degeneration.- 2.2.6 Ataxia.- 2.2.6.1 Spinocerebellar Ataxia.- 2.2.6.2 Friedreich’s Ataxia.- 2.2.6.3 Other Ataxias.- 2.3 Brain Tumors.- 2.3.1 Biological Grading.- 2.3.1.1 Glucose Consumption.- 2.3.1.2 Amino Acid Uptake.- 2.3.1.3 Nucleoside Uptake.- 2.3.2 PET-Guided Stereotactic Biopsy.- 2.3.3 Differentiation Between Recurrent Tumor and Radiation Necrosis.- 2.3.4 Monitoring of Therapy.- 2.3.5 Identification of Hypoxic Tumor Tissue.- 2.3.6 Improving and Planning Therapy.- 2.3.7 New Therapies.- 2.3.8 Other Tracers for Brain Tumors.- 2.3.9 Extracranial Tumors of the Nervous System.- 2.3.10 Detection of Primary Tumors.- 2.3.11 Activation Studies.- 2.3.11.1 Motor Function.- 2.3.11.2 Language.- 2.4 Cerebrovascular Disease.- 2.4.1 Ischemic Stroke.- 2.4.2 Intracerebral and Subdural Hemorrhage.- 2.4.3 Subarachnoid Hemorrhage.- 2.4.4 Remote Effects (Diaschisis).- 2.4.5 Chronic Hemodynamic Impairment.- 2.4.6 Moyamoya Disease.- 2.4.7 Genetic Disorders (MELAS, CADASIL).- 2.4.8 Brain Function and RecoveryAfter Stroke.- 2.4.8.1 Aphasia.- 2.4.8.2 Motor Function.- 2.4.8.3 Neglect.- 2.5 Epilepsy.- 2.5.1 Localization of Epileptogenic Foci.- 2.5.1.1 Temporal Lobe Epilepsy.- 2.5.1.2 Neocortical Focal Epilepsy.- 2.5.1.3 Ictal Studies.- 2.5.1.4 GABA-A and Benzodiazepine Receptors.- 2.5.1.5 Other Transmitters and Receptors.- 2.5.1.6 Inflammatory Lesions and Glial Reaction.- 2.5.2 Progression of Epileptic Lesions.- 2.5.3 Prediction of Surgical Outcome.- 2.5.4 Malformations of Cortical Development.- 2.5.5 Childhood Epileptic Syndromes.- 2.5.6 Language Dominance.- 2.5.7 Effects of Surgical Intervention and Medical Treatment.- 2.5.8 Generalized Epilepsy.- 2.6 Other Neurological Disorders.- 2.6.1 Traumatic Brain Injury.- 2.6.2 Persistent VegetativeState.- 2.6.3 Perinatal Brain Damage.- 2.6.4 Inflammatory Disease.- 2.6.5 Pain.- 2.6.6 Migraine and Cluster Headache.- 2.6.7 Narcolepsy.- 2.6.8 Hypoparathyroidism (Fahr’s Disease).- 2.6.9 Systemic Inherited Metabolic Disorders.- 2.7 Psychiatric Disorders.- 2.7.1 Depression.- 2.7.1.1 Cerebral Blood Flowand Cerebral Metabolic Rate (Glucose).- 2.7.1.2 Serotonin Receptors.- 2.7.1.3 Serotonin Transporters.- 2.7.1.4 Other Transmitter Systems.- 2.7.2 Fatigue.- 2.7.3 Schizophrenia.- 2.7.3.1 CBF and Energy Metabolism.- 2.7.3.2 Activation Studies.- 2.7.3.3 Dopamine Receptors and Dopamine Release.- 2.7.3.4 Other Receptors.- 2.7.3.5 Receptor Binding of Antipsychotic Drugs.- 2.7.4 Anxiety Disorders.- 2.7.4.1 Panic Disorder.- 2.7.4.2 Phobic Disorders.- 2.7.4.3 Obsessive-compulsive Disorder.- 2.7.4.4 Posttraumatic Stress Disorder.- 2.7.5 Drug and Substance Abuse.- 2.7.5.1 Alcoholism.- 2.7.5.2 Cocaine.- 2.7.5.3 Amphetamine and Derivatives.- 2.7.5.4 Opiates.- 2.7.5.5 Nicotine.- 2.7.5.6 Hallucinogens.- 2.7.5.7 Phencyclidine.- 2.7.6 Personality and Behavioral Disorders.- 2.7.6.1 Borderline Personality Disorder.- 2.7.6.2 Violence and Suicide.- 2.7.7 Anorexia Nervosa and Bulimia.- 3 Imaging Brain Function.- 3.1 Blood-Brain Barrier Transfer.- 3.2 Cerebral Blood Flow.- 3.3 Oxygen Consumption.- 3.4 Glucose Consumption.- 3.5 Influence of Brain Function on CBF and Metabolism.- 3.5.1 Wakefulness and Sleep.- 3.5.2 Effect of Drugs.- 3.5.3 The “Resting State”.- 3.5.4 Activation Studies.- 3.6 Tissue Oxygen Pressureand pH.- 3.7 Amino Acid Transport and Protein Synthesis.- 3.7.1 Transport-only Tracers.- 3.7.2 Tracers with Incorporation into Proteins.- 3.7.3 Precursors and Analogues for Transmitter Systems.- 3.8 Nucleosides and DNA Synthesis.- 3.9 Molecular Imaging.- 3.9.1 Herpes Simplex Virus Thymidine Kinase Imaging.- 3.9.2 Reporter Gene Imaging.- 3.9.3 Oligonucleotides.- 3.9.4 Apoptosis and p53.- 3.9.5 Cell Trafficking.- 3.9.6 Angiogenesis.- 3.10 Dopamine System.- 3.10.1 Precursors and Analogues of Dopamine.- 3.10.2 Dopamine Transporter.- 3.10.3 Vesicular Monoamine Transporter.- 3.10.4 D1 Receptors.- 3.10.5 D2 Receptors.- 3.10.6 Studies of Synaptic Dopamine Release.- 3.10.7 Monoamine Oxidase.- 3.11 Cholinergic System.- 3.11.1 Acetylcholine Synthesis.- 3.11.2 Vesicular Acetylcholine Transporter.- 3.11.3 Nicotinic Receptors.- 3.11.4 Muscar inic Receptors.- 3.11.5 Acetylcholine Esterase.- 3.12 Serotonin System.- 3.12.1 Serotonin Precursors.- 3.12.2 Serotonin Transporter.- 3.12.3 Serotonin Receptors.- 3.12.3.1 Serotonin 1A Receptors.- 3.12.3.2 Serotonin 2A Receptors.- 3.13 Gamma-aminobutyric acid (GABA).- 3.13.1 Central Benzodiazepine-binding Sites.- 3.13.2 Peripheral Benzodiazepine Receptors.- 3.14 Glutamate and NMDA Receptors.- 3.15 Adenosine Receptors.- 3.16 Histamine Receptors.- 3.17 Cannabinoid Receptors.- 3.18 Opioid Receptors and Sigma Receptor.- 3.19 Steroid Receptors.- 3.20 Substance P.- 3.21 Secondary Neurotransmitters.- 4 Data Acquisition, Reconstruction, Modeling, Statistics.- 4.1 Positron Emitters and Tracers.- 4.2 Scanners and Detector Systems.- 4.3 Data Acquisition.- 4.4 Image Reconstruction.- 4.5 Motion Detection and Correction.- 4.6 Data Visualization.- 4.7 Image Coregistration.- 4.7.1 Fiducial Markers.- 4.7.2 Matching of Brain Structures.- 4.7.3 Algorithms for Maximization of Similarity.- 4.7.4 PET/CT and PET/MRI Scanners.- 4.8 Anatomical Standardization.- 4.8.1 Orientation of Transaxial Slices.- 4.8.2 Matching of Individual Brains to Image Templates (“Spatial Normalization”).- 4.8.3 Atlases for Identification of Anatomical Structures.- 4.9 Physiological Modeling.- 4.9.1 Blood and Homogeneous Tissue (One Tissue Compartment).- 4.9.1.1 Transport across the BBB.- 4.9.1.2 Cerebral Blood Flow.- 4.9.1.3 Mixed Effects of Transport and Blood Flow.- 4.9.1.4 Measurement of the Partition Coefficient.- 4.9.1.5 Saturable Transport and Enzyme Reactions.- 4.9.2 Metabolism.- 4.9.2.1 Irreversible Metabolism (Metabolic Trapping).- 4.9.2.2 Measurement of Local Cerebral Glucose Metabolism.- 4.9.2.3 The Reference Tissue Model for Dopamine Synthesis and Storage.- 4.9.2.4 Reversible Metabolism or Binding.- 4.9.3 Receptor Binding.- 4.9.3.1 Irreversible Receptor Binding.- 4.9.3.2 Equilibrium Approaches for Quantification of Reversible Receptor Binding.- 4.9.4 Extraction of Model Parameters from Kinetic Data.- 4.10 Quantitative Data Analysis.- 4.10.1 Regions/Volumes of Interest.- 4.10.2 Partial Volume Correction.- 4.10.3 Statistical Models for Quantitative Data.- 4.10.4 Parametric Imaging.- 4.10.5 Statistical Parametric Mapping.- 4.10.6 Lesion Detection and Pattern Recognition.- References.

Más, otros libros, que pueden ser muy parecidos a este:

Último libro similar:
9783642187667 NeuroPET (W.-D. Heiss; K. Herholz; P. Herscovitch)


< para archivar...